Real-time enrollment status for this non-neoplastic hematopoietic and lymphoid cell disorder clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 2:04 AM UTC
| NCT Number | NCT03980769 |
| Recruiting Status | Recruiting |
| Condition | Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder |
| Phase | PHASE2 |
| Target Enrollment | 40 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Fred Hutchinson Cancer Center |
| Last Updated on CT.gov | March 12, 2026 (Mar 12, 2026) |
As of July 19, 2026: Clinical trial NCT03980769 is currently recruiting participants. This phase2 study for non-neoplastic hematopoietic and lymphoid cell disorder is actively seeking new participants at 1 location across the United States. The study is sponsored by Fred Hutchinson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03980769 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03980769 was last updated Mar 12, 2026 (March 12, 2026). HelloStudys verifies this status automatically.